Shortage of Apidra® There will be a temporary supply shortage of Apidra® SoloSTAR® pens in the US starting in late Oct. Due to the possible shortage, from now until April 30, 2012, Apidra vials will have NO CO-Pay for patients with commercial insurance.
Read More »Diabetes In Control
Heart Rate Monitor Plus App
Heart Rate Monitor Plus App This new iPhone App turns your smart phone, and eventually tablet devices, into a sophisticated medical monitor able to capture and transmit vital physiological data. Worcester Polytechnic Institute reports it has developed the app that can measure not only heart rate, but also heart rhythm, respiration …
Read More »FDA Approves Cialis for Benign Prostatic Hyperplasia
The FDA has approved Cialis (tadalafil) as a once-daily treatment for men with erectile dysfunction and benign prostatic hyperplasia, also known as BPH, as well as for BPH alone. BPH is a condition in which the prostate enlarges, which can cause urinary symptoms. Since many men who have ED also …
Read More »Vitamin E Supplementation Linked to Prostate Cancer
An NIH study has established a link between vitamin E supplementation and prostate cancer. Men who took 400 iu’s of vitamin E daily had more prostate cancers compared with men who took a placebo. The findings showed that, per 1,000 men, there were 76 prostate cancers in men who took …
Read More »By 2030, Every Other Person in the US Will Have Diabetes
As reported at the EASD in Lisbon, the number of diabetes patients has increased greatly. IDF estimates that worldwide, there are about 366 million people with diabetes, up from the 300 million reported in 2009. In addition, the estimate also included 4.6 million deaths from diabetes each year. These numbers …
Read More »Highest Testosterone Levels Equal Lowest Risk for CV Events
A new Swedish study has shown that elderly men in the highest quartile of serum testosterone levels have around a 30 percent lower risk of cardiovascular events over five years compared with men in the lower three quartiles….
Read More »Sitagliptin for Type 1 Diabetes
Sitagliptin significantly improved overall glucose control, including postprandial and 24-h glucose control, in adult patients with Type 1 diabetes, while significantly reducing prandial insulin requirements.…
Read More »Weekends Bad for Dialysis
In a new study of more than 36,000 patients who had participated in the ESRD [end-stage renal disease] Clinical Performance Measures Project, investigators found that on the day after the long weekend interdialytic interval, all cause mortality, cardiac mortality, vascular mortality, admissions for cardiovascular disease, as well as infection-related mortality …
Read More »Three Questions Show Type 2 Diabetes Risk
A simple, three-item instrument may be enough to accurately identify those individuals who are at high risk for type 2 diabetes in the next five years….
Read More »BEWARE: Gastric Bypass Increases Risk for New-Onset Alcohol Abuse
Roux-en-Y gastric bypass (RYGB) surgery is associated with an increased risk of developing new-onset alcohol abuse, according to findings from a study of 340 patients who underwent the procedure.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.